Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies

Pediatric Central Nervous System (CNS) neoplasms are the second most prevalent tumors of childhood. Further on, prognosis of this type of neoplasms still remain poor and the comprehension of the etiology and pathogenesis of the disease still remains scarce. Several reports have identified microRNAs as significant molecules in the development of central nervous system tumors and propose that they might compose key molecules underlying oncogenesis. In a previous study we have identified several miRNAs, common to different subtypes of pediatric embryonal CNS malignancies as well as, we have identified miRNAs that manifest significant dynamics with respect to their expression and the neoplasmatic subtype. Overall, 19 tumor cases from children diagnosed with embryonal brain tumors were investigated. As controls, children who suffered a sudden death underwent autopsy and were not present with any brain malignancy were used (13 samples of varying localization). Our experimental approach included microarrays covering 1211 miRNAs, which appeared to manifest tumor-specific dynamics. In conclusion, it appeared that certain miRNAs are neoplasm specific and in particular, their expression manifests linear dynamics. Thus, the investigation of miRNA expression in pediatric embryonal brain tumors might contribute towards the discovery of tumor-specific miRNA signatures, which could potentially afford the identification of gene-specific biomarkers related to diagnosis, prognosis and patient targeted therapy, as well as help us understand oncogenetic dynamics.

[1]  C. Maurer-Morelli,et al.  Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma , 2013, Frontiers in Oncology.

[2]  A. Baruzzi,et al.  Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III , 2014, Molecular oncology.

[3]  T. Jiang,et al.  Identifying Ki-67 specific miRNA–mRNA interactions in malignant astrocytomas , 2013, Neuroscience Letters.

[4]  F. Tzortzatou-Stathopoulou,et al.  Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms , 2014, Journal of Hematology & Oncology.

[5]  George I. Lambrou,et al.  Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach , 2011, Journal of Clinical Bioinformatics.

[6]  H. Fuchs,et al.  MiR‐34a deficiency accelerates medulloblastoma formation in vivo , 2015, International journal of cancer.

[7]  P. Northcott,et al.  Normal and oncogenic roles for microRNAs in the developing brain , 2009, Cell cycle.

[8]  Aliasgar Moiyadi,et al.  Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. , 2010, Journal of cancer research and therapeutics.

[9]  Michael D. Taylor,et al.  MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma* , 2012, The Journal of Biological Chemistry.

[10]  Satoshi O. Suzuki,et al.  MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance , 2010, Clinical Cancer Research.

[11]  K. Cooney,et al.  Intracranial germ cell tumors. , 2000, The oncologist.

[12]  B. Alisjahbana,et al.  Virological failure and drug resistance during first line anti‐retroviral treatment in Indonesia , 2013, Journal of medical virology.

[13]  Giuseppe Basso,et al.  MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma , 2011, PloS one.

[14]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[15]  V. Sée,et al.  Mir-34a Mimics Are Potential Therapeutic Agents for p53-Mutated and Chemo-Resistant Brain Tumour Cells , 2014, PloS one.

[16]  Jian Zheng,et al.  CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186 , 2015, Oncotarget.

[17]  Chiang-Ching Huang,et al.  MicroRNA expression profiling for Molecular Classification of pediatric brain tumors , 2011, Pediatric blood & cancer.

[18]  Michael H Handler,et al.  Survey of MicroRNA expression in pediatric brain tumors , 2011, Pediatric blood & cancer.

[19]  D. Figarella-Branger,et al.  Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Ohgaki,et al.  Genetic Alterations in MicroRNAs in Medulloblastomas , 2012, Brain pathology.

[21]  A. Farcomeni,et al.  MicroRNA profiling in human medulloblastoma , 2009, International journal of cancer.